We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Antibody Test Predicts Cold-Related Asthma Attacks

By LabMedica International staff writers
Posted on 17 Dec 2014
Print article
Image: The MRX Microplate Reader for enzyme-linked immunosorbent assays (Photo courtesy of Dynatech Laboratories).
Image: The MRX Microplate Reader for enzyme-linked immunosorbent assays (Photo courtesy of Dynatech Laboratories).
Image: The ImmunoCAP 250 analyzer for allergy and autoimmunity testing (Photo courtesy of Phadia).
Image: The ImmunoCAP 250 analyzer for allergy and autoimmunity testing (Photo courtesy of Phadia).
A diagnostic marker can be used to identify the risk group for asthma attacks caused by rhinoviruses and this can be assessed with a simple antibody test.

Rhinoviruses (RVs) are the most common cause of respiratory illnesses in children and adults of all ages and are responsible for more than half of all acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD).

Immunologists at the Medical University of Vienna (Austria) working with their colleagues in the UK studied the response to infections with RV16 that were induced in 28 asthmatic patients (11 with mild asthma and 17 with moderate asthma and 11 healthy adult individuals. The healthy adult subjects were non-smoking, non-atopic and non-asthmatic volunteers aged 21 to 55 years. Patients with mild asthma were aged 19 to 53 years taking only short-acting β2 agonists (SABA). The patients with moderate asthma, aged 20–54 years were on SABA) plus inhaled corticosteroid therapy.

Total immunoglobulin E (IgE) levels were measured using ImmunoCAP technology (Phadia; Uppsala, Sweden); healthy median: was 16 IU/mL; mild asthmatics median: was 207 IU/mL; and moderate asthmatics median was 132 IU/mL. Enzyme-linked immunosorbent assays (ELISA) were performed with expressed and purified recombinant RV coat proteins VP1-4, nonstructural proteins as well as N-terminal fragments of VP1 from four RV strains (RV14, 16, 89, C) covering the three known RV groups (RV-A, RV-B and RV-C) and measured specific IgG-subclass-, IgA- and IgM-responses in subjects with different severities of asthma or without asthma before and after experimental infection with RV16. The optical density (OD) values corresponding to the levels of antigen-specific antibodies were measured at 405 and 490 nm in an ELISA reader (Dynatech; Denkendorf, Germany).

The results of the subsequent antibody tests using recombinant virus antigens that were developed showed that the asthmatics who experienced attacks expressed significantly higher antibodies to the structure protein VP1, which is found in all of the known 150 or so rhinovirus strains, than any of the other subjects. The raised antibody response to VP1 now allows all individuals who need particular protection against colds to be identified.

The authors concluded that ultimately serological tests may be helpful for identifying the most common and clinically relevant rhinovirus strains involved in asthma exacerbations and to investigate in cross-sectional studies the possible role of rhinovirus infections in other respiratory diseases, in different geographic populations and age groups including not only children but also adults and elderly persons. The study was published on November 18, 2014, in the journal EbioMedicine.

Related Links:

Medical University of Vienna
Phadia 
Dynatech 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.